THE SARS-COV2 EPOCH AND PROPER MANAGING STRATEGIES TO FACE THE CHALLENGES BOTH IN VIRAL RESEARCH AND TREATMENT

2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.26577/eb.2023.v96.i3.01
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

SARS - COV2 or COVID-19 caused 2020 the greatest pandemic since the end of WW1 and crippled the global healthcare and economy within a relatively short period of time. This article reveals the vaccination issues by understanding the innate and adaptive immune responses and how tightly they are interconnected with each other. There are also to grasp the cellular and humoral parts of immunity and receptor binding recognition mechanisms, antibody neutralization, and antibody mediation both in adaptive and innate immunity to be discussed. The defense strategies of immunity are the objects along with clinical cases to discuss and how effective or not effective vaccination could be in a view of antibody role in creating immunity against this virus. This article will be interesting to those who are planning to design either monoclonal research or strategies for COVID-19 treatment and even vaccination drug design.